Fresenius Medical Care AG
FMS23.410USD
+0.820+3.63%
Cierre 11/21, 16:00（ET）Cotizaciones retrasadas 15 min
6.79BCap. mercado
8.41P/E TTM
Más Datos de Fresenius Medical Care AG Compañía
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Información de Fresenius Medical Care AG
Símbolo de cotizaciónFMS
Nombre de la empresaFresenius Medical Care AG
Fecha de salida a bolsaOct 02, 1996
Director ejecutivoDr. Katarzyna Mazur-Hofsaess
Número de empleados111513
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 02
DirecciónElse-Kroener-Strasse 1
CiudadBAD HOMBURG VOR DER HOHE
Bolsa de valoresTSX Venture Exchange (former Canadian Ventures Exchange)
PaísGermany
Código postal61352
Teléfono4961726090
Sitio Webhttps://www.freseniusmedicalcare.com/
Símbolo de cotizaciónFMS
Fecha de salida a bolsaOct 02, 1996
Director ejecutivoDr. Katarzyna Mazur-Hofsaess
Ejecutivos de Fresenius Medical Care AG
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Dr. Joerg Haering
Dr. Joerg Haering
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
--
--
Ms. Beate Hassdenteufel
Ms. Beate Hassdenteufel
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Marcus Kuhnert
Dr. Marcus Kuhnert
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Stefanie Balling
Ms. Stefanie Balling
Vice Chairman of the Supervisory Board, Employee Representatives
Vice Chairman of the Supervisory Board, Employee Representatives
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Ralf Erkens
Mr. Ralf Erkens
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Dr. Joerg Haering
Dr. Joerg Haering
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
--
--
Ms. Beate Hassdenteufel
Ms. Beate Hassdenteufel
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Marcus Kuhnert
Dr. Marcus Kuhnert
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
North America
14.78B
70.68%
Rest of the world
5.61B
26.84%
Germany
518.03M
2.48%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
Otro
94.20%
Accionistas
Accionistas
Proporción
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
Otro
94.20%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
5.15%
Investment Advisor
2.13%
Hedge Fund
0.35%
Research Firm
0.25%
Pension Fund
0.14%
Family Office
0.02%
Bank and Trust
0.01%
Otro
91.95%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
342
46.84M
7.98%
-1.34M
2025Q2
332
45.25M
7.71%
-2.01M
2025Q1
348
45.06M
7.68%
-2.39M
2024Q4
337
43.96M
7.49%
-3.12M
2024Q3
324
43.49M
7.41%
-1.75M
2024Q2
342
41.23M
7.03%
-8.59M
2024Q1
361
42.90M
7.31%
-5.86M
2023Q4
361
42.80M
7.29%
-6.45M
2023Q3
365
42.72M
7.28%
-7.66M
2023Q2
367
43.73M
7.45%
-13.55M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Pzena Investment Management, LLC
14.66M
2.5%
-714.11K
-4.64%
Jun 30, 2025
Wellington Management Company, LLP
8.20M
1.4%
--
--
Jun 30, 2025
Fiduciary Management, Inc.
5.66M
0.96%
-293.64K
-4.94%
Jun 30, 2025
Dodge & Cox
3.83M
0.65%
-346.60K
-8.30%
Jun 30, 2025
Todd Asset Management LLC
1.24M
0.21%
+756.82K
+156.92%
Jun 30, 2025
Aristotle Capital Management, LLC
1.14M
0.19%
-8.50K
-0.74%
Jun 30, 2025
Parametric Portfolio Associates LLC
972.36K
0.17%
+21.55K
+2.27%
Jun 30, 2025
Morgan Stanley & Co. International Plc
1.26M
0.21%
+1.26M
--
Jun 30, 2025
Janus Henderson Investors
829.14K
0.14%
+300.92K
+56.97%
Jun 30, 2025
Kentucky Teachers' Retirement System
753.50K
0.13%
+455.50K
+152.85%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
Cultivar ETF
0.98%
SGI Enhanced Global Income ETF
0.13%
ActivePassive International Equity ETF
0.08%
Avantis Responsible International Equity ETF
0.04%
Avantis International Equity ETF
0.01%
Pacer Developed Markets International Cash Cws 100
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Unusual Whales Subversive Republican Trading ETF
0%
The Opal International Dividend Income ETF
0%
Ver más
Cultivar ETF
Proporción0.98%
SGI Enhanced Global Income ETF
Proporción0.13%
ActivePassive International Equity ETF
Proporción0.08%
Avantis Responsible International Equity ETF
Proporción0.04%
Avantis International Equity ETF
Proporción0.01%
Pacer Developed Markets International Cash Cws 100
Proporción0%
Unusual Whales Subversive Democratic Trading ETF
Proporción0%
DFA Dimensional International Core Equity 2 ETF
Proporción0%
Unusual Whales Subversive Republican Trading ETF
Proporción0%
The Opal International Dividend Income ETF
Proporción0%
Dividendos
Un total de
1.99B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Fresenius Medical Care AG?
Los cinco principales accionistas de Fresenius Medical Care AG son:
Pzena Investment Management, LLC posee 14.66M acciones, lo que representa el 2.50% del total de acciones.
Wellington Management Company, LLP posee 8.20M acciones, lo que representa el 1.40% del total de acciones.
Fiduciary Management, Inc. posee 5.66M acciones, lo que representa el 0.96% del total de acciones.
Dodge & Cox posee 3.83M acciones, lo que representa el 0.65% del total de acciones.
Todd Asset Management LLC posee 1.24M acciones, lo que representa el 0.21% del total de acciones.
Pzena Investment Management, LLC posee 14.66M acciones, lo que representa el 2.50% del total de acciones.
Wellington Management Company, LLP posee 8.20M acciones, lo que representa el 1.40% del total de acciones.
Fiduciary Management, Inc. posee 5.66M acciones, lo que representa el 0.96% del total de acciones.
Dodge & Cox posee 3.83M acciones, lo que representa el 0.65% del total de acciones.
Todd Asset Management LLC posee 1.24M acciones, lo que representa el 0.21% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Fresenius Medical Care AG?
Los tres principales tipos de accionista de Fresenius Medical Care AG son:
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
¿Cuántas instituciones poseen acciones de Fresenius Medical Care AG (FMS)?
A fecha de 2025Q3, 342 instituciones poseen acciones de Fresenius Medical Care AG, con un valor de mercado combinado de aproximadamente 46.84M, lo que representa el 7.98% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en 0.27%.
¿Cuál es la mayor fuente de ganancias de Fresenius Medical Care AG?
El FY2024, el segmento empresarial -- generó la ganancia más alta para Fresenius Medical Care AG, ascendiendo a -- y representando el --% de la ganancia total.
